Results 121 to 130 of about 715,867 (372)
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT Sepsis‐associated liver injury (SALI) plays a major role in aggravating disease progression and worsening prognosis in patients with sepsis. Macrophage polarization is a key factor in the modulation of SALI progression. Recent studies have shown that human breast milk‐derived exosomes (HBM‐Exos) regulate processes involved in macrophage ...
Zhao‐Bin Yang +3 more
wiley +1 more source
Annals of Hepatology, 2018 Introduction and aim. The evaluation to determine the cause of hepatic encephalopathy consists primarily of laboratory testing to rule out infections and metabolic causes.
Sumit Kumar +4 more
doaj +1 more source
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis [PDF]
, 2007 Hepatorenal syndrome (HRS) is a serious complication of end-stage liver disease, occurring mainly in patients with advanced cirrhosis and ascites, who have marked circulatory dysfunction,1 as well as in patients with acute liver failure.2 In spite of its
Angeli P +21 more
core +4 more sources
The Kaohsiung Journal of Medical Sciences, EarlyView.ABSTRACT This study aimed to assess whether admission plasma lipopolysaccharide‐binding protein (LBP), procalcitonin (PCT), and lactate could improve detection of nosocomial infection in cirrhotic patients presenting with upper gastrointestinal bleeding (UGIB).
Li Chen, Shan‐Shan Dun, Fang Xiao
wiley +1 more source
Annals of Hepatology, 2013 Introduction. Hyponatremia is associated with high mortality and predicts hepatic encephalopathy but its effect on health-related quality of life remains to be established.Material and methods.
Ewa Wunsch +5 more
doaj +1 more source
Therapeutic efficacy of l-ornithine l-aspartate in patients with hepatic encephalopathy [PDF]
, 2015 To determine the efficacy of ornithine-aspartate in reducing blood ammonia levels and clinical improvement, as a part of treatment in hepatic encephalopathy. Material & method: A randomized placebo controlled trial was conducted in 2013 in Jinnah medical
Aidrus, Fadieleh +4 more
core +1 more source
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides [PDF]
, 2016 Nonabsorbable disaccharides have been the mainstay of treatment for hepatic encephalopathy since introduced into clinical practice in 1966. Their beneficial effects reflect their ability to reduce the intestinal production/absorption of ammonia. A recent
Morgan, MY
core +1 more source
Portosystemic shunts and refractory hepatic encephalopathy: patient selection and current options
Hepatic Medicine : Evidence and Research, 2019 Portosystemic shunt (PS) syndrome encompasses a spectrum of disease manifestations ranging from asymptomatic portal hypertension to recurrent and refractory hepatic encephalopathy, ultimately culminating in progressive hepatic failure in patients of ...
C. Philips +4 more
semanticscholar +1 more source
, 2014 Neurotoxicity refers to the direct or indirect effect of chemicals that disrupt the nervous system of humans or animals. Numerous chemicals can produce neurotoxic diseases in humans, and many more are used as experimental tools to disturb or damage the ...
Brust +15 more
core +2 more sources